abstract |
The present invention relates to benzimidazole compounds having dual activity of nitric oxide synthase (NOS) inhibition and agonists at μ-opioid receptors, pharmaceutical and diagnostic compositions containing them, and particularly chronic pain, acute It relates to their medical use as compounds for the treatment or prevention of pain, migraine and neuropathic pain. |